Phaseline

Companies › Innostellar Biotherapeutics

Innostellar Biotherapeutics: clinical trials, targets and expected readouts

2 active drug programs in 6 registered trials: 3 Phase 1, 2 Phase 3, 1 Phase 2; Ophthalmology; next expected readout Dec 2027.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
LX101
Gene therapy for RPE65 mutations
RPE65Phase 3Inherited Retinal Dystrophy Associated With RPE65 Mutations; Inherited Retinal DystrophyDec 2027
LX102
AAV-based gene therapy encoding VEGF-trap (soluble VEGF receptor fusion protein)
VEGFAPhase 3Neovascular Age-Related Macular Degeneration (nAMD); Neovascular Age-Related Macular DegenerationMar 2028

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT06196827LX101Phase 1Inherited Retinal Dystrophy Associated With RPE65 MutationsOphthalmologyDec 2027
NCT07317934LX102Phase 3Neovascular Age-Related Macular Degeneration (nAMD)OphthalmologyMar 2028
NCT06198413LX102Phase 1Neovascular Age-Related Macular DegenerationOphthalmologyJan 2029
NCT06212297LX101Phase 1Inherited Retinal DystrophyOphthalmologyMar 2029
NCT07054632LX101Phase 3Inherited Retinal Dystrophy Associated With RPE65 MutationsOphthalmologyAug 2029
NCT06196840LX102Phase 2Neovascular Age-Related Macular DegenerationOphthalmologyOct 2029

Targets

RPE65 (1) VEGFA (1)

Companies with the same targets

Roche Jiangsu Simcere Pharmaceutical Chengdu Origen Biotechnology Frontera Therapeutics Spark Therapeutics Biotheus AstraZeneca Prestige Biopharma Avirmax Biopharma Eli Lilly

Companies built like this

Neurotech Pharmaceuticals MeiraGTx Ocular UK Tecnoquimicas Adverum Biotechnologies Price Vision Group

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.